RESUMO
OBJECTIVES: There has been limited evidence synthesis examining treatment of ketamine use disorder. We aimed to conduct a systematic review to assess the efficacy and tolerability of pharmacological interventions in the management of ketamine use disorder. METHODS: We searched MEDLINE, EMBASE, PsychINFO, and CENTRAL (Cochrane Central Register of Controlled Trials) from database inception to November 14, 2023, for studies of any design that reported on any pharmacological intervention in the management of ketamine use disorder. We extracted any reported measure of efficacy or tolerability and assessed outcome quality using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework. We planned to combine outcomes using random-effects meta-analysis, where this was not possible results were reported narratively. RESULTS: Twelve studies met the inclusion criteria reporting on 368 participants. These comprised 1 controlled trial, 2 retrospective case series, and 9 case reports. Two studies reported on ketamine intoxication, 6 on withdrawal, and 4 on craving/relapse prevention. All studies reported only descriptive outcomes, and all evidence was of very low quality. Benzodiazepine regimens and haloperidol were reported to have potential utility in intoxication and withdrawal, whereas naltrexone, lamotrigine, and a combination of paliperidone palmitate and bupropion were reported to have potential utility in craving/relapse prevention. CONCLUSIONS: There is a paucity of research into pharmacological management of ketamine use disorder. The limited very low-quality evidence suggests benzodiazepine regimens may be most salient for future exploration in management of ketamine intoxication and withdrawal, whereas case reports suggest naltrexone, lamotrigine, and paliperidone palmitate plus bupropion may potentially merit further investigation with regard to craving/relapse prevention.
RESUMO
AIMS: Wernicke-Korsakoff syndrome (WKS) is commonly associated with chronic alcohol misuse, a condition known to have multiple detrimental effects on thiamine metabolism. This study was conducted to identify genetic variants that may contribute to the development of WKS in individuals with alcohol dependence syndrome through alteration of thiamine transport into cells. METHODS: Exome sequencing data from a panel of genes related to alcohol metabolism and thiamine pathways were analysed in a discovery cohort of 29 individuals with WKS to identify possible genetic risk variants associated with its development. Variant frequencies in this discovery cohort were compared with European frequencies in the Genome Aggregation Database browser, and those present at significantly higher frequencies were genotyped in an additional cohort of 87 alcohol-dependent cases with WKS and 197 alcohol-dependent cognitively intact controls. RESULTS: Thirty non-synonymous variants were identified in the discovery cohort and, after filtering, 23 were taken forward and genotyped in the case-control cohort. Of these SLC19A1:rs1051266:G was nominally associated with WKS. SLC19A1 encodes the reduced folate carrier, a major transporter for physiological folate in plasma; rs1051266 is reported to impact folate transport. Thiamine pyrophosphate (TPP) efflux was significantly decreased in HEK293 cells, stably transfected with rs1051266:G, under thiamine deficient conditions when compared with the efflux from cells transfected with rs1051266:A (P = 5.7 × 10-11). CONCLUSION: This study provides evidence for the role of genetic variation in the SLC19A1 gene, which may contribute to the development of WKS in vivo through modulation of TPP transport in cells.
Assuntos
Alcoolismo , Síndrome de Korsakoff , Proteína Carregadora de Folato Reduzido , Deficiência de Tiamina , Alcoolismo/complicações , Etanol , Ácido Fólico , Variação Genética/genética , Células HEK293 , Humanos , Síndrome de Korsakoff/complicações , Proteína Carregadora de Folato Reduzido/genética , Tiamina , Deficiência de Tiamina/genética , Tiamina Pirofosfato/metabolismoRESUMO
AIM: To offer an estimate of the incidence of anaphylactic reactions to parenteral products containing thiamine used in the treatment of Wernicke's encephalopathy (WE) and make recommendations. METHOD: Review of previously released data on some older products and parenteral thiamine use in some other countries; analysis of sales and adverse incident data on anaphylaxis for a contemporary parenteral product used in the UK, Pabrinex. RESULTS: It was difficult to estimate the incidence of related anaphylactic reactions to Pabrinex in the UK because the number of doses given is unknown. Sales data are only an approximation to doses given because for products with a limited shelf life not all product sold is administered. However, available data indicate that there have been 10 anaphylactic reactions to Pabrinex from between 5,431,235-6,651,947 patient-days (14,880-16,080 years) of treatment. CONCLUSION: It is reasonable to assume that the risk of anaphylaxis is low, and lower than for many other drugs. The risk-benefit ratio for administration is favourable given the potential severity of brain damage in Wernicke-Korsakoff (WK) syndrome. There is a need for international agreement on the reporting of anaphylaxis and on the optimum thiamine therapy for the treatment of WK syndrome. We make recommendations on how this might be achieved.
Assuntos
Tiamina/efeitos adversos , Tiamina/uso terapêutico , Complexo Vitamínico B/efeitos adversos , Complexo Vitamínico B/uso terapêutico , Encefalopatia de Wernicke/complicações , Anafilaxia/epidemiologia , Anafilaxia/etiologia , Humanos , Incidência , Infusões Parenterais , Medição de Risco , Tiamina/administração & dosagem , Deficiência de Tiamina , Complexo Vitamínico B/administração & dosagemRESUMO
BACKGROUND: The interpretation of genetic studies on alcohol dependence may be confounded by the co-occurrence of substance dependence, psychiatric disorders and alcohol-related comorbidities, for example, cirrhosis. Significant single-marker and haplotypic associations between polymorphisms in the zinc finger gene, ZNF699, and alcohol dependence were reported in the Irish Affected Sib Pair Study of Alcohol Dependence population, one-third of whom had co-occurring substance dependence while 80% had identified psychiatric comorbidity. The aim of this study was to explore variant ZNF699 associations with alcohol dependence while exercising controls for potential confounders. METHODS: The study population was comprised of 1449 alcohol-dependent cases and 1283 population controls; all were of British or Irish ancestry. None of the cases had a history of dependence on other substances, and the frequency of comorbid depression was low. A separate, ancestry-matched cohort of 196 opioid-dependent cases was also included. Genotyping for the four previously identified SNPs of interest in ZNF699 was performed using K-Biosciences Competitive Allele Specific PCR. RESULTS: No single-marker associations were found between polymorphisms in ZNF699 and alcohol dependence per se. A significant allelic association was found between rs7254880 in ZNF699 and alcohol-related cirrhosis (n=292), using cases with no biopsy evidence of liver disease (n=314) as controls (P=0.013). Significant allelic associations were also found between rs12460279 (P=0.028), rs7252865 (P=0.012) and rs10854142 (P=0.016) in ZNF699 and opioid dependence. CONCLUSION: Phenotypic variation in study populations may contribute towards the nonreplication of genetic association studies on alcohol dependence; controls for recognised confounding variables should be exercised whenever possible.
Assuntos
Alcoolismo/genética , Proteínas de Transporte/genética , Fibrose/genética , Alcoolismo/etnologia , Alcoolismo/patologia , Alcoolismo/psicologia , Estudos de Casos e Controles , Feminino , Fibrose/etiologia , Estudos de Associação Genética , Predisposição Genética para Doença , Humanos , Masculino , Fenótipo , Polimorfismo de Nucleotídeo Único , População Branca/genéticaRESUMO
Certain single nucleotide polymorphisms (SNPs) in genes encoding alcohol dehydrogenase (ADH) enzymes confer a significant protective effect against alcohol dependence syndrome (ADS) in East Asian populations. Recently, attention has focused on the role of these SNPs in determining ADS risk in European populations. To further elucidate these associations, SNPs of interest in ADH1B, ADH1C and the ADH1B/1C intergenic region were genotyped in a British and Irish population (ADS cases n = 1076: controls n = 1027) to assess their relative contribution to ADS risk. A highly significant, protective association was observed between the minor allele of rs1229984 in ADH1B and ADS risk [allelic P = 8.4 × 10(-6) , odds ratio (OR) = 0.26, 95 percent confidence interval, 0.14, 0.49]. Significant associations were also observed between ADS risk and the ADH1B/1C intergenic variant, rs1789891 [allelic P = 7.2 × 10(-5) , OR = 1.4 (1.2, 1.6)] and three non-synonymous SNPs rs698, rs1693482 and rs283413 in ADH1C. However, these associations were not completely independent; thus, while the ADH1B rs1229984 minor allele association was independent of those of the intergenic variant rs1789891 and the three ADH1C variants, the three ADH1C variants were not individually independent. In conclusion, the rare ADH1B rs1229984 mutation provides significant protection against ADS in this British and Irish population; other variants in the ADH gene cluster also alter ADS risk, although the strong linkage disequilibrium between SNPs at this location precluded clear identification of the variant(s) driving the associations.
Assuntos
Álcool Desidrogenase/genética , Alcoolismo/genética , Predisposição Genética para Doença/genética , Polimorfismo de Nucleotídeo Único/genética , Estudos de Casos e Controles , Feminino , Variação Genética , Genótipo , Humanos , Irlanda/etnologia , Masculino , Reino Unido/etnologiaRESUMO
AIMS: The aim of the study was to review recent research on the interplay between genes, environment and epigenetic factors in risky drinking in adolescents and the impact of neurobiological determinants on early alcohol-related cognitive deficits in young people. METHODS: Narrative review. RESULTS: There is consensus that the brain and the behaviour are shaped during development by the combined effects of genes, childhood experiences, environment and hormonal variations. Epigenetic factors seem to play a role in linking the expression of genes with stress and external experiences during brain maturation and development. Evidence on the interaction between genes and environmental factors illustrates that, in adolescence, external factors play a more important role than genetic factors on the risk of developing alcohol problems later on in life. CONCLUSIONS: Adolescence is a crucial stage of brain development; intervening early and applying certain prevention programmes may halt the progression of alcohol misuse.
Assuntos
Comportamento do Adolescente , Consumo de Bebidas Alcoólicas/genética , Transtornos do Sistema Nervoso Induzidos por Álcool/genética , Dano Encefálico Crônico/etiologia , Interação Gene-Ambiente , Adolescente , Dano Encefálico Crônico/prevenção & controle , Epigenômica , Humanos , Fatores de RiscoRESUMO
Alcohol dependence is a common, complex and debilitating disorder with genetic and environmental influences. Here we show that alcohol consumption increases following mutations to the γ-aminobutyric acidA receptor (GABAAR) ß1 subunit gene (Gabrb1). Using N-ethyl-N-nitrosourea mutagenesis on an alcohol-averse background (F1 BALB/cAnN x C3H/HeH), we develop a mouse model exhibiting strong heritable preference for ethanol resulting from a dominant mutation (L285R) in Gabrb1. The mutation causes spontaneous GABA ion channel opening and increases GABA sensitivity of recombinant GABAARs, coupled to increased tonic currents in the nucleus accumbens, a region long-associated with alcohol reward. Mutant mice work harder to obtain ethanol, and are more sensitive to alcohol intoxication. Another spontaneous mutation (P228H) in Gabrb1 also causes high ethanol consumption accompanied by spontaneous GABA ion channel opening and increased accumbal tonic current. Our results provide a new and important link between GABAAR function and increased alcohol consumption that could underlie some forms of alcohol abuse.
Assuntos
Consumo de Bebidas Alcoólicas/genética , Receptores de GABA-A/genética , Transtornos Relacionados ao Uso de Álcool/genética , Animais , Feminino , Genes Dominantes , Células HEK293 , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Núcleo Accumbens/fisiologia , Mutação Puntual , Receptores de GABA-A/metabolismoRESUMO
An inadequate supply of thiamine (vitamin B) to the brain can result in Wernicke's encephalopathy, which is an acute neuropsychiatric disorder This article explains the known risk of thiamine deficiency in people who are dependent on or misuse alcohol. The importance of making parenteral vitamin supplements available to patients in a community alcohol service is outlined. A project that has provided intramuscular thiamine supplementation to reduce the likelihood of long-term brain damage is described.
Assuntos
Alcoolismo/fisiopatologia , Encefalopatia de Wernicke/prevenção & controle , Humanos , Reino Unido , Vitaminas/administração & dosagem , Encefalopatia de Wernicke/etiologiaRESUMO
Wernicke's Encephalopathy is an acute neuro-psychiatric condition caused by an insufficient supply of thiamine (Vitamin B1) to the brain. If undiagnosed or inadequately treated, it is likely to proceed to Korsakoff's Syndrome. Wernicke's Encephalopathy can result from dietary deficiency alone and this form is usually successfully treated, with little chance of Korsakoff's Syndrome supervening. On the other hand, thiamine deficiency associated with alcohol misuse/dependence may require up to 1 gram of thiamine IV in the first 24 hours to be treated successfully. The reasons for this difference in treatment will be discussed. Thiamine diphosphate acts as a co-factor for a number of thiamine-dependent enzymes. Thiamine deficiency leads to a reduction in the activity of these enzymes, and this leads to alterations in mitochondrial activity, impairment of oxidative metabolism, decreased energy status and eventually selective neuronal death. The damage caused by the combination of thiamine deficiency and alcohol metabolism probably interferes with adequate thiamine transport at a number of sites in the body, including the blood-brain barrier, as well as causing damage to the apoenzymes which then require higher concentrations of thiamine to work normally. The accumulated damage is likely to render the use of oral thiamine therapeutically inadequate since the body is unable to produce high enough concentrations of thiamine in the blood to traverse the blood-brain barrier. Some individuals are probably genetically predisposed to develop Wernicke's. Long before individuals with alcohol misuse or dependence develop Wernicke's Encephalopathy the neurons and other cells of the body are functioning sub-optimally because of the inadequate supply of thiamine and the neurotoxic effect of alcohol. This relative deficiency initiates a series of pathological changes which accumulate and further interfere with the supply of thiamine and its utilisation at a time when the requirements are increased. The best treatment for Korsakoff's Syndrome is timely recognition of Wernicke's Encephalopathy and appropriate intervention and prevention.
Assuntos
Síndrome de Korsakoff/terapia , Encefalopatia de Wernicke/terapia , Alcoolismo/patologia , Animais , Encéfalo/patologia , Modelos Animais de Doenças , Humanos , Síndrome de Korsakoff/complicações , Síndrome de Korsakoff/etiologia , Síndrome de Korsakoff/genética , Deficiência de Tiamina/complicações , Deficiência de Tiamina/genética , Encefalopatia de Wernicke/complicações , Encefalopatia de Wernicke/etiologia , Encefalopatia de Wernicke/genéticaRESUMO
OBJECTIVES: Alcoholism and affective disorders are both strongly comorbid and heritable. We have investigated the genetic comorbidity between bipolar affective disorder and alcoholism. METHODS: A genome-wide allelic association study of 506 patients from the University College London bipolar disorder case-control sample and 510 ancestrally matched supernormal controls. One hundred forty-three of the bipolar patients fulfilled the Research Diagnostic Criteria diagnosis of alcoholism. A total of 372 193 single nucleotide polymorphisms (SNPs) were genotyped. Genes previously shown to be associated with alcoholism and addiction phenotypes were then tested for association in the bipolar alcoholic sample using gene-wise permutation tests of all SNPs genotyped within a 50-kb region flanking each gene. RESULTS: Several central nervous system genes showed significant (P<0.05) gene-wise evidence of association with bipolar alcoholism. The genes implicated, which replicated genes previously shown to be associated with alcoholism were: cadherin 11, collagen type 11 α2, neuromedin U receptor 2, exportin7, and semaphorin-associated protein 5A. The SNPs most strongly implicated in bipolar alcoholism, but, which did not meet conventional genome-wide significance criteria were the insulin-like growth factor-binding protein 7, carboxypeptidase O, cerebellin 2, and the cadherin 12 genes. CONCLUSION: We have confirmed the role of some genes previously shown to be associated with alcoholism in the comorbid bipolar alcoholism subgroup. In this subgroup, bipolar disorder may lower the threshold for the phenotypic expression of these alcoholism susceptibility genes. We also show that some genes may independently increase susceptibility to affective disorder and alcoholism.
Assuntos
Alcoolismo/epidemiologia , Alcoolismo/genética , Transtorno Bipolar/epidemiologia , Transtorno Bipolar/genética , Predisposição Genética para Doença , Estudo de Associação Genômica Ampla , Caderinas/genética , Estudos de Casos e Controles , Comorbidade , Feminino , Marcadores Genéticos , Humanos , Londres/epidemiologia , Masculino , Polimorfismo de Nucleotídeo Único/genética , Reprodutibilidade dos TestesAssuntos
Alcoolismo/genética , Alelos , Crime/psicologia , Loci Gênicos/genética , Predisposição Genética para Doença , Proteínas Serina-Treonina Quinases/genética , Receptores de Dopamina D2/genética , Alcoolismo/enzimologia , Estudos de Casos e Controles , Marcadores Genéticos , Humanos , Polimorfismo de Nucleotídeo Único/genéticaAssuntos
Eritrócitos/enzimologia , Anamnese , Deficiência de Tiamina/diagnóstico , Transcetolase/sangue , Encefalopatia de Wernicke/diagnóstico , Biomarcadores/sangue , Encéfalo/metabolismo , Humanos , Valor Preditivo dos Testes , Fatores de Risco , Tiamina/sangue , Deficiência de Tiamina/enzimologia , Tiamina Pirofosfato/sangue , Encefalopatia de Wernicke/enzimologia , Encefalopatia de Wernicke/prevenção & controleAssuntos
Alcoolismo/complicações , Encefalopatias/etiologia , Doenças Fetais/etiologia , Complicações na Gravidez/etiologia , Alcoolismo/terapia , Encefalopatias/embriologia , Feminino , Humanos , Cuidado Pré-Concepcional , Gravidez , Complicações na Gravidez/terapia , Resultado da Gravidez , Cuidado Pré-Natal , Efeitos Tardios da Exposição Pré-Natal , Psicoterapia BreveAssuntos
Envelhecimento/psicologia , Consumo de Bebidas Alcoólicas/psicologia , Dano Encefálico Crônico/induzido quimicamente , Dano Encefálico Crônico/psicologia , Adolescente , Adulto , Feminino , Humanos , Injeções , Síndrome de Korsakoff/patologia , Síndrome de Korsakoff/psicologia , Deficiência de Magnésio/psicologia , Imageamento por Ressonância Magnética , Gravidez , Proteômica , Tiamina/administração & dosagem , Tiamina/uso terapêutico , Deficiência de Tiamina/complicações , Vitaminas/administração & dosagem , Vitaminas/uso terapêutico , Encefalopatia de Wernicke/diagnósticoRESUMO
AIMS: The Korsakoff syndrome is a preventable memory disorder that usually emerges (although not always) in the aftermath of an episode of Wernicke's encephalopathy. The present paper reviews the clinical and scientific literature on this disorder. METHODS: A systematic review of the clinical and scientific literature on Wernicke's encephalopathy and the alcoholic Korsakoff syndrome. RESULTS: The Korsakoff syndrome is most commonly associated with chronic alcohol misuse, and some heavy drinkers may have a genetic predisposition to developing the syndrome. The characteristic neuropathology includes neuronal loss, micro-haemorrhages and gliosis in the paraventricular and peri-aqueductal grey matter. Lesions in the mammillary bodies, the mammillo-thalamic tract and the anterior thalamus may be more important to memory dysfunction than lesions in the medial dorsal nucleus of the thalamus. Episodic memory is severely affected in the Korsakoff syndrome, and the learning of new semantic memories is variably affected. 'Implicit' aspects of memory are preserved. These patients are often first encountered in general hospital settings where they can occupy acute medical beds for lengthy periods. Abstinence is the cornerstone of any rehabilitation programme. Korsakoff patients are capable of new learning, particularly if they live in a calm and well-structured environment and if new information is cued. There are few long-term follow-up studies, but these patients are reported to have a normal life expectancy if they remain abstinent from alcohol. CONCLUSIONS: Although we now have substantial knowledge about the nature of this disorder, scientific questions (e.g. regarding the underlying genetics) remain. More particularly, there is a dearth of appropriate long-term care facilities for these patients, given that empirical research has shown that good practice has beneficial effects.
Assuntos
Síndrome de Korsakoff/psicologia , Síndrome de Korsakoff/terapia , Alcoolismo/complicações , Alcoolismo/terapia , Encéfalo/patologia , Química Encefálica/genética , Química Encefálica/fisiologia , Humanos , Síndrome de Korsakoff/induzido quimicamente , Síndrome de Korsakoff/genética , Encefalopatia de Wernicke/induzido quimicamente , Encefalopatia de Wernicke/genética , Encefalopatia de Wernicke/psicologia , Encefalopatia de Wernicke/terapiaRESUMO
AIMS: In the scientific literature it has been repeatedly hypothesized that there is a heritable susceptibility to thiamine deficiency comparable to other hereditary metabolic disorders. The aim of this paper is to review the most recent knowledge on the genetic susceptibility to the development of alcohol-related Wernicke-Korsakoff syndrome (WKS). METHODS: A literature review was carried out looking at the molecular genetics studies performed in alcohol-dependent patients affected by WKS. RESULTS: A genetic component in the pathogenesis of WKS has been postulated since the late seventies. Since then, very few genetic studies have been carried out on candidate genes such as thiamine-dependent enzymes, alcohol-metabolizing enzymes and GABA receptors. The findings are controversial and not conclusive. Several authors reported the important role of the thiamine transporters in the pathogenesis of the thiamine deficiency disorders. Our findings on SLC19A2 and SLC19A3 suggest a potential role of these two genes in the pathophysiology of alcohol-related thiamine deficiency but further studies need to be carried out. CONCLUSIONS: The WKS may be a very complex, multifactorial disorder where the interaction of multiple genes and environment plays an important role in the pathogenesis. However, it is still plausible that megaphenic gene effects are responsible for WKS susceptibility and the thiamine transport genes are good candidates for having such a role. Further genetic studies are definitely needed to investigate the association with candidate genes or linkage with hot spot areas.
Assuntos
Dano Encefálico Crônico/genética , Etanol/toxicidade , Alcoolismo/genética , Alcoolismo/patologia , Animais , Dano Encefálico Crônico/patologia , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Humanos , Deficiência de Tiamina/genética , Deficiência de Tiamina/psicologiaRESUMO
AIMS: To develop clinical guidelines to identify individuals who misuse alcohol and are at risk of developing Wernicke's Encephalopathy (WE). METHOD: Non-systematic literature review of studies which includes a careful clinical record of the development of signs and symptoms of thiamine deficiency and in which the diagnosis of WE has been confirmed at autopsy. RESULTS: The review of the clinical findings in cases of WE, diagnosed at autopsy, shows a consistent pattern of signs and symptoms. The pattern appears to be similar regardless of whether the thiamine deficiency is related to nutritional problems alone or associated with alcohol misuse. CONCLUSIONS: The assessment of the degree of thiamine deficiency and the diagnosis of WE remain a clinical evaluation, and guidelines are suggested to help the clinician. Since neurotoxicity due to the metabolism of excessive alcohol in patients with chronic and severe alcohol dependence may be an important factor in determining long-term outcome of treatment, this must form part of the overall evaluation.
Assuntos
Encefalopatia de Wernicke/diagnóstico , Encefalopatia de Wernicke/etiologia , Alcoolismo/complicações , Alcoolismo/diagnóstico , Alcoolismo/prevenção & controle , Humanos , Guias de Prática Clínica como Assunto/normas , Deficiência de Tiamina/complicações , Deficiência de Tiamina/diagnóstico , Encefalopatia de Wernicke/prevenção & controleRESUMO
AIMS: A translation into English of the case history section of Carl Wernicke's original manuscript of 1881, with a discussion on its relevance for clinicians today. METHODS: A copy of Carl Wernicke's original German text was obtained by one of the authors (CCHC) and translated into English from the old German by a professional translator. RESULTS: The translation was subsequently agreed by native German speaking referees, and minor changes made. CONCLUSIONS: The authors studied the translation in detail and concluded that Wernicke's description had stood the test of time. The diagnosis of Wernicke's Encephalopathy remains a clinical one.